Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk

被引:2
作者
Calvo, Virginia [1 ]
Niazmand, Emetis [2 ,3 ]
Carcereny, Enric [4 ]
Rodriguez-Abreu, Delvys [5 ]
Cobo, Manuel [6 ]
Lopez-Castro, Rafael [7 ]
Guirado, Maria [8 ]
Camps, Carlos [9 ]
Ortega, Ana Laura [10 ]
Bernabe, Reyes [11 ]
Massuti, Bartomeu [12 ]
Garcia-Campelo, Rosario [13 ]
del Barco, Edel [14 ]
Gonzalez-Larriba, Jose Luis [15 ]
Bosch-Barrera, Joaquim [16 ]
Martinez, Marta [1 ]
Torrente, Maria [1 ]
Vidal, Maria-Esther [2 ,3 ]
Provencio, Mariano [1 ]
机构
[1] Hosp Univ Puerta Hierro Majadahonda, Med Oncol Dept, Manuel de Falla 1, Madrid 28222, Spain
[2] TIB Leibniz Informat Ctr Sci & Technol, Hannover, Germany
[3] L3S Res Ctr, Hannover, Germany
[4] Catalan Inst Oncol ICO Badalona, Badalona Appl Res Grp Oncol B ARGO, Med Oncol Dept, Badalona, Spain
[5] Hosp Univ Insular Gran Canaria, Med Oncol Serv, Las Palmas Gran Canaria, Spain
[6] Hosp Univ Reg & Virgen Victoria, Unidad Gest Clin Interctr Oncol Med, BIONAND, IBIMA, Malaga, Spain
[7] Hosp Clin Univ Valladolid, Med Oncol Dept, Valladolid, Spain
[8] Hosp Gen Univ Elche, Med Oncol Dept, Elche, Spain
[9] Hosp Gen Univ Valencia, Med Oncol Dept, Valencia, Spain
[10] Hosp Univ Jaen, Med Oncol Dept, Jaen, Spain
[11] Hosp Univ Virgen Rocio, Med Oncol Dept, Seville, Spain
[12] Hosp Gen Univ Doctor Balmis, Med Oncol Dept, Alicante, Spain
[13] Hosp Univ A Coruna, Med Oncol Dept, La Coruna, Spain
[14] Hosp Univ Salamanca IBSAL, Med Oncol Dept, Salamanca, Spain
[15] Hosp Clin San Carlos, Med Oncol Dept, Madrid, Spain
[16] Univ Hosp Dr Josep Trueta, Catalan Inst Oncol, Girona Biomed Res Inst IDIBGI CERCA, Med Oncol Dept,Precis Oncol Grp OncoGIR Pro, Girona, Spain
关键词
Cancer registry; Family history; Lung cancer; Spain; DEATHS; WOMEN;
D O I
10.1016/j.lungcan.2024.107920
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Lung Cancer (LC) is a multifactorial disease for which the role of genetic susceptibility has become increasingly relevant. Our aim was to use artificial intelligence (AI) to analyze differences between patients with LC based on family history of cancer (FHC). Materials and methods: From August 2016 to June 2020 clinical information was obtained from Thoracic Tumors Registry (TTR), a nationwide database sponsored by the Spanish Lung Cancer Group. In addition to descriptive statistical analysis, an AI-assisted analysis was performed. The German Technical Information Library supported the merging of data from the electronic medical records and database of the TTR. The results of the AI-assisted analysis were reported using Knowledge Graph, Unified Schema and descriptive and predictive analyses. Results: Analyses were performed in two phases: first, conventional statistical analysis including 11,684 patients of those 5,806 had FHC. Median overall survival (OS) for the global population was 23 months (CI 95 %: 21.39-24.61) in patients with FHC versus 21 months (CI 95 %: 19.53-22.48) in patients without FHC (NFHC), p < 0.001. The second AI-assisted analysis included 5,788 patients of those 939 had FHC. 58.48 % of women with FHC had LC. 9.53 % of patients had an EGFR or HER2 mutation or ALK translocation and at least one relative with cancer. A family history of LC was associated with an increased risk of smoking-related LC. Non-smokers with a family history of LC were more likely to have an EGFR mutation in NSCLC. In Bayesian network analysis, 55 % of patients with a family history of LC and never-smokers had an EGFR mutation. Conclusion: In our population, the incidence of LC in patients with a FHC is higher in women and younger patients. FHC is a risk factor and predictor of LC development, especially in people <= 50 years. These results were confirmed by conventional statistics and AI-assisted analysis.
引用
收藏
页数:13
相关论文
共 36 条
  • [1] [Anonymous], 2024, Las cifras del cancer en Espana
  • [2] Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study
    Arrieta, Oscar
    Caballe-Perez, Enrique
    Hernandez-Pedro, Norma
    Romero-Nunez, Eunice
    Lucio-Lozada, Jose
    Castillo-Ruiz, Cesar
    Acevedo-Castillo, Karla
    Alvarez-Gomez, Rosa Maria
    Molina-Garay, Carolina
    Jimenez-Olivares, Marco
    Carrillo-Sanchez, Karol
    Mendoza-Caamal, Elvia Cristina
    Cardona, Andres F.
    Remon, Jordi
    Alaez-Verson, Carmen
    [J]. LUNG CANCER, 2024, 194
  • [3] Global Epidemiology of Lung Cancer
    Barta, Julie A.
    Powell, Charles A.
    Wisnivesky, Juan P.
    [J]. ANNALS OF GLOBAL HEALTH, 2019, 85 (01):
  • [4] Bouckaert R.R., 2008, Artificial Intelligence Tools, V11, P369, DOI DOI 10.1201/B10391-16
  • [5] Genetics of lung-cancer susceptibility
    Brennan, Paul
    Hainaut, Pierre
    Boffetta, Paolo
    [J]. LANCET ONCOLOGY, 2011, 12 (04) : 399 - 408
  • [6] Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors
    Brenner, Darren R.
    Hung, Rayjean J.
    Tsao, Ming-Sound
    Shepherd, Frances A.
    Johnston, Michael R.
    Narod, Steven
    Rubenstein, Warren
    McLaughlin, John R.
    [J]. BMC CANCER, 2010, 10
  • [7] The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015
    Brown, Katrina F.
    Rumgay, Harriet
    Dunlop, Casey
    Ryan, Margaret
    Quartly, Frances
    Cox, Alison
    Deas, Andrew
    Elliss-Brookes, Lucy
    Gavin, Anna
    Hounsome, Luke
    Huws, Dyfed
    Ormiston-Smith, Nick
    Shelton, Jon
    White, Ceri
    Parkin, D. Max
    [J]. BRITISH JOURNAL OF CANCER, 2018, 118 (08) : 1130 - 1141
  • [8] American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility
    Bruinooge, SS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2397 - 2406
  • [9] Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung)
    Citarella, Fabrizio
    Takada, Kazuki
    Cascetta, Priscilla
    Crucitti, Pierfilippo
    Petti, Roberta
    Vincenzi, Bruno
    Tonini, Giuseppe
    Venanzi, Francesco M.
    Bulotta, Alessandra
    Oresti, Sara
    Greco, Carlo
    Ramella, Sara
    Crino, Lucio
    Delmonte, Angelo
    Ferrara, Roberto
    Di Maio, Massimo
    Gurrieri, Fiorella
    Cortellini, Alessio
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [10] Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium
    Cote, Michele L.
    Liu, Mei
    Bonassi, Stefano
    Neri, Monica
    Schwartz, Ann G.
    Christiani, David C.
    Spitz, Margaret R.
    Muscat, Joshua E.
    Rennert, Gad
    Aben, Katja K.
    Andrew, Angeline S.
    Bencko, Vladimir
    Bickeboeller, Heike
    Boffetta, Paolo
    Brennan, Paul
    Brenner, Hermann
    Duell, Eric J.
    Fabianova, Eleonora
    Field, John K.
    Foretova, Lenka
    Friis, Soren
    Harris, Curtis C.
    Holcatova, Ivana
    Hong, Yun-Chul
    Isla, Dolores
    Janout, Vladimir
    Kiemeney, Lambertus A.
    Kiyohara, Chikako
    Lan, Qing
    Lazarus, Philip
    Lissowska, Jolanta
    Le Marchand, Loic
    Mates, Dana
    Matsuo, Keitaro
    Mayordomo, Jose I.
    McLaughlin, John R.
    Morgenstern, Hal
    Mueeller, Heiko
    Orlow, Irene
    Park, Bernard J.
    Pinchev, Mila
    Raji, Olaide Y.
    Rennert, Hedy S.
    Rudnai, Peter
    Seow, Adeline
    Stucker, Isabelle
    Szeszenia-Dabrowska, Neonila
    Teare, M. Dawn
    Tjonnelan, Anne
    Ugolini, Donatella
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 (13) : 1957 - 1968